Early study data puts Terns among obesity drug contenders

BioPharma Dive September 9, 2024
Jonathan Gardner

A once-daily pill the biotech is developing helped some people with obesity lose more than 5% of their weight in a month, spurring a stock bump and plans to bring the drug into further testing.

Dive Brief:

• An experimental weight loss pill developed by biotechnology company Terns Pharmaceuticals helped some people with obesity lose more than 5% of their body weight in a small Phase 1 trial, supporting plans to move the drug into mid-stage testing next year, the company said Monday.
• Trial volunteers who received the highest tested dose of Terns’ drug lost nearly 5 percentage points more weight than those who received a placebo over 28 days, the company said. Two-thirds lost over 5% of their body...

Today's Sponsors

Today's Sponsor